neuropathy semaglutide GLP-1 Drug Can Cause Rare, Potentially Blinding Side Effect, EMA Warns Semaglutide Linked to Nerve Damage

Key Takeaways of the GLP-1 Receptor Agonist Market Based on drug class, the liraglutide segment is projected to dominate, holding a share of 26.5% in 2026

When regain reaches a predefined threshold (usually 10-15 pounds), restart medication

They made me feel really comfortable and explained the procedure really well

Health officials and clinicians increasingly consider GLP-1 drugs to be a major advancement in treating obesity, a condition that disproportionately affects older adults and contributes to a range of costly and debilitating illnesses

Its expansion and/or activation can protect against diet-induced obesity